{
  "url": "https://openlegislation.uk/cosmetic-products-safety-regulations-2003/schedule-7/part-I",
  "json_url": "https://openlegislation.uk/cosmetic-products-safety-regulations-2003/schedule-7/part-I.json",
  "legislation": "uksi/2003/835",
  "legislation_title": "The Cosmetic Products (Safety) Regulations 2003",
  "legislation_url": "https://openlegislation.uk/cosmetic-products-safety-regulations-2003",
  "path": "schedule/7/part/I",
  "kind": "part",
  "number": "I",
  "heading": "UV FILTERS LISTED IN ANNEX VII, PART 1 OF THE DIRECTIVE AS UV FILTERS WHICH COSMETIC PRODUCTS MAY NOT CONTAIN EXCEPT SUBJECT TO THE RESTRICTIONS LAID DOWN",
  "text": "(1)\n(2)\n(3)\n(4)\n(5)\nReference Number\nName of substance\nMaximum concentration of substance in product\nOther requirements\nRequired information\n1\n4-Aminobenzoic acid [PABA]\n5 per cent\n—\n—\n2\nN,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl)anilinium methyl sulphate [Camphor benzalkonium methosulfate]\n6 per cent\n—\n—\n3\nHomosalate (INN)\n10 per cent\n—\n—\n4\nOxybenzone (INN) [Benzophenone-3]\n10 per cent\n—\nContains oxybenzone. (Not required when concentration is not more than 0.5 per cent, and when the substance is only intended to protect the product.)\n5\nENTRY DELETED.\n6\n2-Phenylbenzimidazole-5-sulphonic acid [Phenylbenzimidazole sulfonic acid] and its potassium, sodium and triethanolamine salts\n8 per cent (expressed as acid)\n—\n—\n7\n3,3'(1,4-Phenylenedimethylene)- bis(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-ylmethanesulfonic acid) [Terephthalylidene dicamphor sulfonic acid] and its salts\n10 per cent (expressed as acid)\n—\n—\n8\n1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione (Avobenzone (INN)) [Butyl methoxy dibenzoylmethane]\n5 per cent\n—\n—\n9\nα-(2-Oxoborn-3-ylidene)toluene-4-sulphonic acid [Benzylidene camphor sulfonic acid] and its salts\n6 per cent (expressed as acid)\n—\n—\n10\n2-Ethylhexyl 2-cyano-3,3-diphenylacrylate [Octocrylene]\n10 per cent (expressed as acid)\n—\n—\n11\nPolymer of N-[(2 and 4)-[(2-oxoborn-3-ylidene)methyl]benzyl]acrylamide [Polyacrylamidomethyl benzylidene camphor]\n6 per cent\n—\n—\n12\n2-Ethylhexyl 4-methoxycinnamate [Octyl methoxycinnamate]\n10 per cent\n—\n—\n13\nEthoxylated ethyl-4-aminobenzoate [PEG-25 PABA]\n10 per cent\n—\n—\n14\nIsopentyl 4-methoxycinnamate [Isoamyl p-methoxycinnamate]\n10 per cent\n—\n—\n15\nTris(2-ethylhexyl) 4,4'4\"-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate [Octyl triazone]\n5 per cent\n—\n—\n16\n2-(2H-Benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-(trimethylsilyloxy)disiloxan-1-yl]propyl]phenol [Drometrizole trisiloxane]\n15 per cent\n—\n—\n17\nBis(2-ethylhexyl) 4,4'-[6-tert-butylcarbamoylanilino)-1,3,5-triazine-2,4-diyldiimino]dibenzoate\n10 per cent\n—\n—\n18\n3-(4-Methylbenzylidene)bornan-2-one [4-Methylbenzylidene camphor]\n4 per cent\n—\n—\n19\n3-Benzylidenebornan-2-one [3-Benzylidene camphor]\n2 per cent\n—\n—\n20\n2-Ethylhexyl salicylate [Octyl salicylate]\n5 per cent\n—\n—\n21\n2-Ethylhexyl 4-dimethylaminobenzoate [Octyl dimethyl PABA]\n8 per cent\n—\n—\n22\n2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid [Benzophenone-4] and its sodium salt [Benzophenone-5] (Sulisobenzone (INN) and Sulisobenzone sodium (INNM))\n5 per cent (expressed as acid)\n—\n—\n23\n2-2'-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol]\n10 per cent\n—\n—\n24\ndiSodium 2,2'-(1,4-phenylene)bis(1H-benzimidazole-4,6-disulfonate)\n10 per cent (expressed as acid)\n—\n—\n25\n5,5'-Bis(2-ethylhexyloxy)-2,2'-(6-p-methoxyphenyl-1,3,5-triazine-2,4-diyl)diphenol\n10 per cent\n—\n—\n26\nα-(Trimethylsilyl)-w-(trimethylsilyloxy)poly- [dimethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)-vinyl]- phenoxy]-1-methyleneethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)vinyl)]- phenoxy]prop-1-enyl)silylene] where there are usually 60 polymeric units, of which the first part of the copolymer provides 56 (Dimethicodiethyl/Benzalmalonate)\n10 per cent\n—\n—\n27\nTitanium dioxide.\n25 per cent\n—\n—",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2003/835/schedule/7/part/I",
    "retrieved_at": "2026-10-29T06:27:30.309640+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}